KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $121.6 million.

  • Eli Lilly's Short-term Investments fell 1860.78% to $121.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.6 million, marking a year-over-year decrease of 1860.78%. This contributed to the annual value of $154.8 million for FY2024, which is 4188.82% up from last year.
  • Per Eli Lilly's latest filing, its Short-term Investments stood at $121.6 million for Q3 2025, which was down 1860.78% from $170.1 million recorded in Q2 2025.
  • Eli Lilly's 5-year Short-term Investments high stood at $170.1 million for Q2 2025, and its period low was $37.1 million during Q3 2021.
  • Its 5-year average for Short-term Investments is $115.3 million, with a median of $123.4 million in 2023.
  • Examining YoY changes over the last 5 years, Eli Lilly's Short-term Investments showed a top increase of 27231.4% in 2021 and a maximum decrease of 3750.0% in 2021.
  • Over the past 5 years, Eli Lilly's Short-term Investments (Quarter) stood at $90.1 million in 2021, then soared by 60.71% to $144.8 million in 2022, then decreased by 24.65% to $109.1 million in 2023, then surged by 41.89% to $154.8 million in 2024, then decreased by 21.45% to $121.6 million in 2025.
  • Its Short-term Investments stands at $121.6 million for Q3 2025, versus $170.1 million for Q2 2025 and $127.4 million for Q1 2025.